UnitedHealth Group (NYSE: UNH) is a leading diversified health and well-being company in the United States. As a major health insurance provider, its core activities involve offering a wide range of health benefit plans and services. The company operates in a competitive industry, facing challenges such as managing rising medical costs.
On July 16, 2026, UnitedHealth Group announced its second-quarter financial results. The company reported an earnings per share (EPS) of $6.38. This result beat the general analyst consensus of $4.87. As highlighted by Zacks, this figure also surpassed its specific consensus estimate of $4.94 and shows significant earnings growth from the $4.08 per share earned one year prior.
In addition to strong earnings, UnitedHealth Group posted revenue of $112.03 billion for the quarter. This surpassed the analyst expectation of $110.81 billion. This revenue figure also represents an increase from the nearly $111.62 billion that UnitedHealth Group reported in the same quarter of the previous year, marking continued top-line growth.
Following the announcement, UnitedHealth Group's stock price increased by over 7%, as noted by Schaeffer's Research. UnitedHealth Group also raised its profit forecast for the full year, now projecting adjusted earnings between $19.50 and $20.00 per share. This positive update is attributed to effective medical costs management.
The company's current valuation includes a Price-to-Earnings (P/E) ratio of 33.98. This metric suggests investors are willing to pay nearly $34 for every dollar of UnitedHealth Group's annual earnings. Other indicators of financial health include a Debt-to-Equity ratio of 0.75, which compares the company's total debt to its shareholder equity.
